The Alzheimer’s disease treatment Ebixa is a drug treatment prescribed to Alzheimer’s patients that display moderate to advanced symptoms of the disease.
Ebixa is not a cure for Alzheimer’s disease but treats Alzheimer’s symptoms by stabilizing the decline in cognition and daily function.
The Alzheimer’s treatment Ebixa is one of a group of drugs classed as a NMDA receptor antagonists.
Alzheimer’s disease causes nerve cells to leak large quantities of glutamate which leads to excessive interaction with the NMDA receptors resulting in the disease or death of the receiving nerve cells. With the Alzheimer’s disease treatment Ebixa, the drug interacts with the NMDA receptors and prevent glutamate from interacting with the receiving cells. This results in the normal transmission of nerve messages between nerve cells.
With such an Alzheimer’s disease treatment, there is a slowing in the decline of memory and cognition in those patients with Alzheimer’s disease.
Ebixa can be used by itself or in conjunction with other Alzheimer’s disease treatments.
People treated with the Alzheimer’s disease treatment Ebixa may take as long as 12 weeks to show signs of responding to the drug treatment.
Recent Comments